Indica
Backed by cutting edge technology, an uncompromising focus on ease-of-use and dedicated customer service, Indica Labs’ software and services are being used to make vital discoveries in pathology labs and research organizations around the world.
+1 (505) 492 0979
sales: info@indicalab.com
support: support@indicalab.com

News

Indica Labs / News

INDICA LABS 5th Annual London Quantitative Pathology and HALO User Group Meeting

Indica Labs invites you to attend our 5th Annual London Quantitative Pathology and HALO User Group Meeting: Hot Topics in Immuno-oncology and Deep Learning Wednesday, 5 December 2018 London Heathrow Marriott Hotel London, UK Indica Labs is pleased to announce our 5th Annual London Quantitative Pathology Symposia and HALO User Group Meeting to be held in conjunction with the Digital Pathology & AI Congress in London on the 5th December 2018 from 5 to 9 PM.  Dinner will be served to all pre-registered workshop attendees...

Transforming tissue-based translational research with advanced multiplexing technologies, image analysis and cloud collaboration

PRESENTED BY Dr. Sean Downing, PhD |  Director Customer Engagement, Ultivue 25 October, 2018 8:00 PDT | 11:00 EDT | 16:00 BST | 17:00 CEST With its high spatial heterogeneity and biological complexity, the tumor immune microenvironment presents a characterization challenge for translational researchers.  Conventional immunohistochemistry (IHC) methods only provide insight into a limited number of markers of interest.  In this 60-minute webinar, Dr. Sean Downing from Ultivue will explain how they are overcoming these limitations and extracting meaningful, highly multiplexed biomarker data from whole...

Indica Labs Preconference Workshop – Path Visions, San Diego, CA USA – November 4, 2018

HALO AI – The Power of Deep Learning in the Hands of the Pathologist If you’ve attended any digital pathology meetings over the past couple of years, you have heard artificial intelligence, neural networks or deep learning mentioned at least once.  If you don’t have a background in computer science, you might be wondering how these technologies relate to one another and how they differ from all the other image analysis and pattern recognition tools that have been used in digital...

Press Release: New Mexico Governor Susana Martinez Announces Expansion of Pathology Software Company – Indica Labs Will Create Up To 58 New Jobs

Albuquerque, N.M. - Today, Governor Susana Martinez announced that Indica Labs, a homegrown technology company, will create up to 58 new jobs and invest more than $3 million in its new headquarters location in Albuquerque. The expansion is being supported by New Mexico's closing fund, LEDA. "We’re proud to see another great employer expand in New Mexico as we continue to grow our thriving science and technology sector," said Governor Martinez. "It's incredible to see our reforms working to help in...

Indica Labs Quantitative Digital Pathology Amsterdam Lunch & Learn

Indica Labs invites you to attend our 2018 Quantitative Digital Pathology Lunch & Learn Wednesday, 17 October 2018 Dutch Design Hotel Artemis Amsterdam, Netherlands 12:00 - 14:30 The event will feature customer presenters representing diverse organizations, including biotech, pharma, and academic medical centers across Europe. These customers will discuss how they are using HALO image analysis to achieve their research objectives with an emphasis on biomarker analysis in oncology, particularly immuno-oncology. Additionally, there will be presentations from Indica Labs introducing new features in HALO, and demonstrations...

Upcoming Webinar – HALO® Analysis Applications in Neuroscience Research

PRESENTED BY Alyssa Myers |  Application Scientist, Indica Labs, Inc. Wednesday 15th August, 2018 8:00 AM PST | 11:00 AM EST | 4:00 PM BST In this one hour webinar, Indica Labs' Application Scientist, Alyssa Myers, will discuss how the HALO platform can be used for quantitative analysis of whole slide images relevant to neuroscience researchers. Alyssa will introduce HALO modules for quantifying and measuring: Axon diameter, myelin sheath thickness and G-ratio in optic nerve Beta-amyloid plaques in cortex and hippocampus Resting and active microglia...

Press Release: New paradigms for quantitative assessment of PD-1 and PD-L1 using the HALO® image analysis platform described in two recent publications

New Mexico, USA 21/6/2018 – Indica Labs, Inc announced today that the HALO® platform was used in two recent research papers that describe novel digital image analysis protocols for PD-1 and PD-L1 quantification and may help to identify potential responders to PD1/PD-L1 targeted immunotherapy in non-small cell lung cancer and melanoma. In the first study published in Nature Medicine this month, PD-1+ tumor-infiltrating lymphocytes (TILs) from non-small cell lung cancer (NSCLC) were subdivided into groups based on PD-1 expression and characterized...

Upcoming Webinar – Computational pathology: A new platform to empower personalized immunotherapy

Hosted by Dr. Viktor Koelzer, M.D., FMH Pathology from Institute of Cancer and Genomic Science, University of Birmingham | Wellcome Trust Centre for Human Genetics, University of Oxford on Thursday 12th July 2018 (8:00 AM PST | 11:00 AM EST | 4:00 PM BST). This webinar is a “must see” for anyone interested in PD-1/PD-L1 targeted immunotherapy and quantitative methods for biomarker assessment in immuno-oncology.  Clinical success of immunotherapy targeting the PD-1/PD-L1 axis has significantly improved the outcome of patients with a...

Upcoming Webinar – RNAscope® ISH Quantification using the HALO® Image Analysis Platform

Hosted by Dr. Gordon Jiang from Beth Israel Deaconess Medical Center | Harvard Medical School, and Dr. Julia Jones from Cancer Research UK | Cambridge on Thursday 21st June 2018 (8:00 AM PST | 11:00 AM EST | 4:00 PM BST). The RNAscope® ISH technology allows for gene expression to be visualized within the morphological context of the tissues in a reliable, reproducible manner and serves as an alternative to immunohistochemistry (IHC) when reliable antibodies are not available for a particular target.   Reliable image...

Indica Labs Digital Pathology & AI USA Lunch & Learn

Indica Labs invites you to attend our 2018 Digital Pathology & AI Lunch & Learn Monday June 25, 2018 Radisson Martinique on Broadway New York City, NY 1:30 PM - 4:00 PM Presenters representing diverse organizations, including biotech, pharma and academic medical centers across the United States, will discuss how they are using HALO image analysis software and services is used to achieve their research objectives with an emphasis on biomarker analysis in oncology, particularly immuno-oncology. Additionally, there will be presentations from Indica Labs introducing new...

INDICA LABS TOKYO QUANTITATIVE PATHOLOGY & AI USER GROUP MEETING

Indica Labs invites you to attend our 2018 Tokyo User Group Meeting  Tuesday May 8, 2018 Keio Plaza Hotel Tokyo Shinjuku-Ku, Tokyo, Japan Indica Labs invites you to attend our Tokyo Quantitative Pathology & AI User Group Meeting being held in conjunction with the 4th Digital Pathology Congress - Asia on Tuesday 8th May 2018 from 9:00 to 11:30 am at the Keio Plaza Hotel. インディカ・ラボは、京王プラザホテルにて5月8日午前9時分-11時30分に開催される、病理定量的解析・AIユーザーグループミーティングIn東京にご招待いたします。 The meeting will feature customer presenters representing diverse organizations, including biotech, pharma and academic medical centers. These customers will discuss how they are using HALO...

INDICA LABS 1ST BASEL QUANTITATIVE PATHOLOGY USER MEETING

Indica Labs invites you to attend our 2018 Basel User Group Meeting  Thursday May 17, 2018 Airport Hotel Basel Basel Switzerland 12:00 PM – 6:00 PM The event will feature customer presenters representing diverse organizations, including biotech, pharma, and academic medical centers across Europe. These customers will discuss how they are using HALO image analysis to achieve their research objectives with an emphasis on biomarker analysis in oncology, particularly immuno-oncology. Additionally, there will be presentations from Indica Labs introducing new features in HALO, and demonstrations on...

Indica Labs 2018 US User Group Meeting Series

Indica Labs invites you to attend a session in our 2018 US User Group Meeting Series.  Each session will feature customer presenters representing diverse organizations, including biotech, pharma and academic medical centers across the United States. These customers will discuss how they are using HALO image analysis is used to achieve their research objectives with an emphasis on biomarker analysis in oncology, particularly immuno-oncology. Additionally, there will be presentations from Indica Labs introducing new features in HALO, and demonstrations on HALO Link,...

Indica Labs 2nd London Quantitative Pathology User Meeting

HALO and HALO Link users representing a diverse set of organizations, including pharma, biotech, and academic medical centres across Europe will discuss how they are using image analysis to achieve their research objectives with an emphasis on biomarker analysis in oncology and immuno-oncology on Wednesday, November 29th 2017. Confirmed guest speakers from CRUK/Cambridge Institute, CRUK/Beatson Institute, AstraZeneca, and University of St. Andrews. Additionally, Indica Labs will demonstrate HALO, HALO-AI and HALO Link with emphasis on new features and developments.  The audience will include both...

The Netherlands Cancer Institute selects the HALOTM image analysis platform to expand its immuno-oncology research capabilities

Corrales, NM – October 24, 2017 – Indica Labs, the leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce selection of the HALO image analysis platform by the Netherlands Cancer Institute (NKI) for in situ analysis of multiplexed biomarkers in tumor tissues. NKI will be using the HALO platform to analyze images captured from their Perkin Elmer Vectra® 3 multispectral imaging system.   Together with the Perkin Elmer OpalTM 7 reagent kits, this system allows simultaneous...

Upcoming Webinar – Targeting Immuno-oncology Markers in the Tumor Microenvironment

Hosted by Dr. Kate Lillard Tunstall, CSO, Indica Labs, and Dr. Travis Hollmann, Memorial Sloan Kettering Cancer Center on Thursday 16th November 2017 (8 am PDT | 11 am PDT | 4 pm BST). This two-part webinar is a must see for anyone interested in spatially-resolved multiplexing for immuno-oncology or analysis of multi-spectral images, such as the PerkinElmer Vectra® 3 or Vectra® PolarisTM platforms. In the first half hour, Dr. Kate Tunstall from Indica Labs will give a brief introduction to HALO's...

Upcoming Webinar – Introducing HALO-AI: Moving deep learning out of the computer lab and into the hands of the pathologist

Hosted by Vlado Ovtcharov, Lead Algorithm Engineer, and Dr. Kate Lillard Tunstall, CSO, Indica Labs, Inc on Wednesday 25th October 2017 (8 am PDT | 11 am PDT | 4 pm BST). If you’ve attended any digital pathology or medical imaging meetings over the past couple of years, you have heard artificial intelligence or deep learning mentioned at least once. If you are not a computer scientist, algorithm engineer or image analyst, you might be wondering how these tools differ from...

University of Cambridge Laboratories select HALO AITM deep learning technology to advance metabolic disease research

Corrales, NM - October 5, 2017 - Indica Labs Inc headquartered in Corrales, New Mexico, is pleased to announce the selection of the newly developed deep learning classification tool, HALO AITM, by the University of Cambridge Metabolic Research Laboratories (MRL) in England. HALO AI or ‘Artificial intelligence’ is a convolutional neural network platform resulting from years of effort by the Indica Labs’ research & development team, whose goal was to build a deep learning tool that could decipher and assess the...

MolecularMD Announces Partnership with Indica Labs to Support Improved Clinical Trial Histopathology Workflows Integrating Digital Biomarker Analysis Services

Portland, OR – September 29, 2017 – MolecularMD, a provider of molecular and tissuebased clinical trial assays and diagnostics for oncology based drug development programs, has announced a partnership agreement with Indica Labs, a leader in digital pathology imaging tools and services. The collaboration between the companies leverages MolecularMD’s diagnostic clinical testing solutions with Indica Labs’ digital biomarker analysis services to enable an efficient transition of pre-clinical research to the diagnostic setting and deployment of advanced image analysis workflows. Mindful...

Indica Labs Appoints a Vice President, Pharma Services

Dr. Keith J. Kaplan | July 31, 2017  | Source: Indica Labs Indica Labs announced today that Douglas Bowman has been appointed Vice President, Pharma Services. Mr. Bowman will play an important role as the company develops its image analysis and biomarker assay services business to support preclinical and clinical biomarker assays for Indica Lab’s academic, biotech, and pharma customers. Doug was previously at Takeda Pharmaceuticals for 11 years where he was responsible for developing quantitative biomarker assays to support the Oncology...

HALO® Deep Learning Technology Awarded for Automated Breast Cancer Metastasis Staging

Corrales, NM - April 24th 2017 - Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.  The international challenge engaged commercial and academic teams worldwide to develop deep-learning algorithms to analyze 500 whole-slide H&E lymph node images and calculate TNM staging of 100 breast cancer patients. The HALO Deep Learning solution was the highest ranking commercial solution and third overall among 32 accepted teams. Indica’s CEO Steven Hashagen remarked “Our team is...

Indica Labs opens office in Tokyo to provide dedicated support to customers in Japan インディカ・ラボ社 国内拠点新設について

Tokyo, 9 January, 2017 – Indica Labs expanded its international presence again this month with the establishment of a new office in Tokyo, Japan and the recruitment of Hideya Makino to manage Japanese operations.  Mr. Makino has over 14 years of combined experience in the fields of microscopy, digital pathology and image analysis gained through his previous positions at Roche, Leica, Aperio, and Roper Technologies. Indica Labs’ has been steadily growing its global business since 2012.  In addition to Tokyo, Indica Labs...

Indica Labs invites you to Cruise Chicago with us

Indica Labs, in conjunction with Global Engage Digital Pathology Congress 2017, formally invites you to take in a unique view of the Chicago Skyline while enjoying dinner and drinks with your conference delegates as you cruise the Chicago River on this 90 ft luxury yacht! Event Date Sunday, July 9th, 2017 Event Times 6:00 PM                    Guest Loading 6:30 PM Prompt      Yacht Departure for Sunset Cruise - Dinner & Drinks will be served 8:30 PM        ...

Indica Labs advance immuno-oncology capabilities with innovative quantification of multiplexed chromogenic immunohistochemistry

Corrales, NM – 2 November, 2016 – Indica Labs, a leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce the release of a new module for multiplex chromogenic IHC analysis using HALO™.  The Multiplex IHC module can separate up to five stains simultaneously and analyze any subcellular compartment, nucleus, cytoplasm or membrane, making it ideally suited for applications in immuno-oncology where multiple markers are required to characterize distinct immune and tumor cell populations within...

November 15th Webinar: Introducing HALO Link, Collaborative Pathology Information System

Indica Labs invites you to attend our November webinar: Introducing HALO Link, Collaborative Pathology Information System Tuesday November 15th | 8 AM PST | 11 AM EST | 4 PM GMT Presented by Kate Tunstall Ph.D, CSO Designed with image analysis users in mind, Indica Labs introduces HALO LinkTM, a collaborative digital pathology information system which integrates seamlessly with the HALOTM image analysis platform.  In this 45-minute webinar, we will demonstrate how HALO Link can be used to: Organize whole slide images into studies and grant collaborators remote access...

You’re Invited to our European Quantitative Pathology Meeting

You're Invited  Indica Labs would like to formally invite you to our European Quantitative Pathology Meeting in London which will be held on Wednesday 30th November from 12:00-5 PM at the London Marriott Heathrow Hotel. Customer presenters representing diverse organizations,including pharma, biotech, and academic medical centres across Europe will discuss how they are using HALO image analysis to achieve their research objectives with an emphasis on biomarker analysis in oncology, particularly immuno-oncology. Additionally, there will be presentations from Indica Labs introducing new features in HALO and STRATA and...

Webinar September 28th | Evaluating Immune Checkpoint Biomarkers in Melanoma using HALO and STRATA

Case Study using HALO™ and STRATA™: Biomarkers of Anti-tumor Immune Activity Associate with Survival in Melanoma Wednesday Septmber 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School  Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive.  PD-L1 expression is often a marker of an ongoing CD8+ cytotoxic T-cell-mediated anti-tumor immune response, and thus, patients with PD-L1-positive melanomas have improved overall survival relative to those with...

Join Indica Labs at the 2nd Digital Pathology Congress in Philadelphia

Indica Labs' Sales Application Scientist Adam Smith will be presenting on the STRATA Platform July 14th from 11:45-12:15 at the 2nd Digital Pathology Congress in Philadelphia. His presentation will focus on the connection of Image Analysis resulting in the collection of millions of data points and data point combinations. STRATA provides a connection between this image analysis data and patient data in order to determine how these two data silos are correlated. From these correlations we can use STRATA to...

ACD and Indica Labs Present a Joint Webinar Event

Current State-of-the-Art Tissue-Based RNA Analysis with RNAscope Technology and Quantitative Analysis with the HALO Image Analysis Platform  June 1st, 2016, 8 am PDT | 11 am EDT | 4 pm BST (GMT+1) Advanced Cell Diagnostics’ RNAscope® platform is fast becoming a routinely used method for target validation and biomarker development based on in situ gene expression analysis. ACD has nearly 9000 target RNA-specific probes in use and there are over 400 publications with the method. RNAscope® technology enables faster and more rigorous target and biomarker development: it is...

Webinar: Introducing Strata

Introducing STRATATM| Mining tissue-based analysis data to identify predictive and/or prognostic factors using STRATA, an integrated tissue informatics platform  May 3rd, 2016, 8 am PDT | 11 am EDT | 4 pm BST (GMT+1)   Combining multiplexed, spatially-resolved analysis capabilities with the fastest processing speeds in the industry, Indica Labs' HALO™ analysis platform allows scientists to quickly generate vast amounts of biomarker expression data from large patient populations.  As the volume of analysis data increases, the challenge shifts from data collection to data mining....

Indica Labs announce release of HALO 2.0

Corrales, NM – 11 April, 2016 – Indica Labs, a leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce the latest release of its flagship image analysis platform, HALOTM.  Established as the industry’s fastest and most user-friendly analysis platform, HALO 2.0 adds new capabilities, support for new file formats, and even greater ease-of-use. Those familiar with HALO will recognize the new, more modern look-and-feel of HALO 2.0 including interchangeable dark and light skins designed to...

Inaugural East Coast HALO User Group to be held in Cambridge, MA on February 11, 2016

  Indica Labs would like to formally invite you to the Inaugural East Coast HALOTM User Group Meeting which will be held on 11th February, 2016 from 1- 5 PM at the Boston Marriott Cambridge, Kendall Square. Lunch (12-1 PM) and happy hour refreshments (5-6 PM) will be available to all registered attendees. Both current HALO users and those interested in learning about HALO and other Indica Labs software are welcome to attend and participate. Indica Labs CSO, Dr. Kate Lillard, and...

Boehringer Ingelheim Principal Scientist Alex Klimowicz and Indica Labs CSO Kate Lillard to present at Pathology Visions Boston

  Discoveries from the field:  Expediting drug developments and clinical trials with digital pathology and HALO image analysis Alex Klimowicz, PhD, Principal Scientist, Boehringer Ingelheim Pharmaceuticals Kate Lillard Tunstall, PhD, CSO, Indica Labs   In this 60-minute presentation, our speakers will detail how the HALO image analysis platform has been used to analyze biomarkers in translational research and drug development, respectively. So please join us October Tuesday 13th at 8 a.m. in the Carlton Ballroom at the Westin Waterfront Hotel, at the Pathology Visions Conference....